Mutated EGFR-IN-3 T12131
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Mutated EGFR-IN-3 is a ATP-competitive and highly selective allosteric dibenzodiazepinone EGFR(L858R/T790M) and EGFR(L858R/T790M/C797S) inhibitor(IC50 of 12 nM and 13 nM, respectively. )
CAS nr:
2375107-27-8
Purity:
98%
Molecular Weight:
508,59
SMILES:
O=C1C2=CC(OC3=CC=C(N4CCN(C)CC4)C=C3)=CC=C2NC5=CC=C(F)C=C5N1CC6=CC=CC=C6
Formula:
C31H29FN4O2
Pathway:
Tyrosine Kinase/Adaptors,Angiogenesis,JAK/STAT signaling
Target:
EGFR,EGFR,EGFR
